EMA accepts Alvotech and Advanz Pharma’s AVT05 MAA
The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for Alvotech and Advanz Pharma’s AVT05, a proposed biosimilar to Johnson & Johnson’s (J&J) Simponi ...
BEN STOCK ANNOUNCEMENT: BFA Law Informs Franklin Resources Investors of Stock Drop on CFPB Investigation and Encourages You to Contact the Firm
New York, New York-- (Newsfile Corp. - November 5, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Franklin Resources, Inc. (NYSE: BEN) for potential ...